R2M Pharma, Inc. logo

R2M Pharma, Inc.

R2M is a collaborative pharmaceutical company that works with you throughout the discovery and development phase.

17 employees · est. 2017 · South San Francisco, United...

VS
Skyhawk Therapeutics logo

Skyhawk Therapeutics

We Use Small Molecules To Modify RNA Splicing

81 employees · est. 2016 · Waltham, United States

Skyhawk Therapeutics is the older company (2017 vs 2016); Skyhawk Therapeutics is the larger of the two.

Side-by-Side Comparison

R2M Pharma, Inc. Skyhawk Therapeutics
Founded
2017 2016 older
Headquarters
South San Francisco, United States Waltham, United States
Employees
17 81 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health and Wellness
Funding Stage
Not tracked yet Series Unknown
Total Funding
Not tracked yet $181.20M
Funding Rounds
Not tracked yet 6
Services
Not tracked yet Development of RNA-targeting small molecules, Conducting clinical trials, Collaborative drug development with pharma companies, Expanding internal pipeline for neurology, oncology, and fibrotic diseases
Target Customers
Not tracked yet Patients with Huntington's Disease, Pharmaceutical Companies, Biotechnology Researchers
Taxonomy
Pharmaceutical Company, Research Organization, Small Molecules, Preclinical Development, Drug Discovery, Medical Indications, Collaborative, Innovation, Biopharmaceuticals Small Molecule Therapeutics, RNA Splicing Modification, Drug Discovery, RNA-based Disease Treatment, Cancer Therapeutics, Neurological Condition Treatments, Proprietary Technology, Therapeutics Development, Exon Skipping, RNA Expression Correction, Binding Pocket Targeting, Sequence Specificity, Structural Specificity, Waltham-based
Website
r2mpharma.com skyhawktx.com
R2M Pharma, Inc. logo

About R2M Pharma, Inc.

R2M Pharma, Inc. is a fast growing biotechnology research organization founded in 2017, with a focus on the discovery of high quality small molecules preclinical development compounds for the treatment of unmet medical indications. Their slogan, "R2M is a collaborative pharmaceutical company that wo...

Skyhawk Therapeutics logo

About Skyhawk Therapeutics

Skyhawk Therapeutics, founded in 2016, is at the forefront of drug discovery and development within the Biotechnology and Health and Wellness industries. Stationed in Waltham, Massachusetts, this innovative company is pioneering the treatment of diseases with small molecules designed to modify RNA s...

We will tell you when either one moves

BounceWatch watches R2M Pharma, Inc. and Skyhawk Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at R2M Pharma, Inc. and Skyhawk Therapeutics — by email.

Frequently Asked Questions

R2M Pharma, Inc. — R2M is a collaborative pharmaceutical company that works with you throughout the discovery and development phase.. Skyhawk Therapeutics — We Use Small Molecules To Modify RNA Splicing. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
R2M Pharma, Inc. has raised undisclosed funding while Skyhawk Therapeutics has raised $181.20M.
R2M Pharma, Inc. and Skyhawk Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare R2M Pharma, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at R2M Pharma, Inc. on 15 Sep 2024, and Skyhawk Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes